Login / Signup

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.

Elaine M BinkleyPierre L TriozziLisa RybickiSusan AchbergerWayne AldrichArun D Singh
Published in: The British journal of ophthalmology (2019)
NCT01100528.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • skin cancer
  • randomized controlled trial
  • open label
  • basal cell carcinoma